The broad-based institutional accumulation, especially from passive funds and sovereign wealth, suggests the stock is being added to core portfolios ahead of the volixibat PSC Phase 3 data. However, the 45-day 13F reporting lag means these positions may already be partially unwound. Monitor upcoming Q1 2026 13F filings for confirmation of continued accumulation. The Point72 near-exit is a contrarian signal worth watching.
MIRM drugs
MIRM drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $99.54entry
- T+1 · 5mo ago −0.20%α −0.74% · $99.35
- T+5 · 5mo ago +2.51%α +2.08% · $102.04
- T+20 · 4mo ago +28.29%α +26.40% · $127.70
- T+60 · 2mo ago +1.37%α −3.03% · $100.90
How similar events traded
Executive Summary
A strong institutional buying cluster emerged in MIRM during Q4 2025, with 9 buyers adding $189.1M in net new positions versus 3 sellers reducing by $60.7M. The buying was dominated by mega-passive funds (State Street, BofA, Wells Fargo) and sovereign/asset managers (Norges Bank, Wellington, Deutsche Bank), suggesting broad-based conviction in Mirum's commercial-stage rare-disease portfolio. The cluster aligns with the company's strong revenue growth trajectory from Livmarli and the upcoming Phase 3 readout for volixibat in PSC.
Key Financial Metrics
Institutional Positions
Net institutional flow: $128.4M
▲ Buyers (9)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| State Street | ADD | +59.2% | $169.4M | $70.6M |
| BofA | ADD | +82.7% | $56.4M | $27.7M |
| Wells Fargo | DOUBLED | +326.5% | $9.1M | $7.1M |
| Norges Bank | NEW | Not reported | $20.8M | $20.8M |
| Wellington Management Group | ADD | +56.6% | $97.8M | $39.8M |
| Ameriprise Financial | ADD | +33.7% | $21.4M | $6.6M |
| Envestnet Asset Management | DOUBLED | +201.2% | $1.6M | $1.1M |
| Deutsche Bank | NEW | Not reported | $14.7M | $14.7M |
| Mirae Asset Global Investments | DOUBLED | +377.5% | $733.0K | $590.0K |
▼ Sellers (3)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Invesco | TRIM | -36% | $7.4M | -$2.3M |
| Point72 | NEAR_EXIT | -75.9% | $58.0M | -$42.9M |
| Morgan Stanley | TRIM | -36.5% | $49.1M | -$15.5M |
Key Facts
- 9 institutional buyers added $189.1M in net new positions during Q4 2025, while 3 sellers reduced by $60.7M
- State Street added $70.6M (+59.2% shares), Wellington added $39.8M (+56.6%), Norges Bank initiated a $20.8M new position
- Point72 made a near-exit, cutting 75.9% of its position ($42.9M sold), while Morgan Stanley trimmed $15.5M (-36.5%)
- Mega-passive funds (State Street, BofA, Wells Fargo) accounted for $105.4M of the buying, signaling index-driven accumulation
- Sovereign wealth (Norges Bank) and active asset managers (Wellington, Deutsche Bank) added $75.3M in new/added positions
Financial Impact
9 institutional buyers accumulated $189.1M in net new positions, while 3 sellers reduced holdings by $60.7M, for a net institutional inflow of $128.4M
Risk Factors
- 13F data is 45+ days stale; the cluster may have been partially or fully unwound since quarter-end
- Point72's near-exit ($42.9M sold) suggests a loss of conviction from a sophisticated quant fund
- Mega-passive buying may reflect index rebalancing rather than fundamental conviction in Mirum's pipeline
- Volixibat PSC Phase 3 readout is binary, a miss would reverse the accumulation thesis
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-MIRM-2025-Q4 |
Track record
27 reports on MIRM
4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +23.79% at T+60 after the Apr 27, 2026 report. 7 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $92.28 settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 3/10 Entry $93.54 settles Feb 12
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $93.33 settles Feb 10
- Nov 10, 20266d ago 8-K Bullish 6/10 Entry $94.42 settles Feb 8
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $93.54 settles Feb 3
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $96.97 settles Feb 2
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $85.81 settles Jan 26
- Oct 26, 202621d ago 8-K Bullish 6/10 Entry $85.56 settles Jan 25
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $79.62 settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers